[ Price : $8.95]
Two Morrison Foerster attorneys list five takeaways from an FDA virtual public meeting on artificial intelligence/machine learning...[ Price : $8.95]
CDER associate director for controlled substances Marta Sokolowska shares issues raised at an FDA/Duke-Margolis Center for Health ...[ Price : $8.95]
Six stakeholders submit their comments on FDAs PDUFA 7 commitment letter.[ Price : $8.95]
FDA awards Cardinal Health a $750,000 contract to implement an 18-month real world evidence study to help the agency advance RWE i...[ Price : $8.95]
A Bloomberg Law report says FDA is likely to place greater emphasis on real-world data in future regulatory decisions.[ Price : $8.95]
FDA approves a labeling modification on Impulse Dynamics Optimizer Smart medical device, allowing the removal of a normal sinus rh...[ Price : $8.95]
FDA joins with Canadian and UK regulators to promote 10 guiding principles for good machine learning practice for medical devices.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Nabriva Therapeutics Xenlet...